- Report
- March 2025
- 185 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- February 2025
- 187 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- February 2025
- 185 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- February 2025
- 186 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- January 2025
- 182 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- January 2025
- 185 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- January 2025
- 183 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- August 2024
- 187 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- July 2024
- 180 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- July 2024
- 185 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- July 2024
- 182 Pages
Global
From €3378EUR$3,825USD£2,922GBP
€3974EUR$4,500USD£3,438GBP
- Report
- April 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,430GBP
- Report
- May 2025
- 120 Pages
Global
From €4195EUR$4,750USD£3,629GBP
- Report
- May 2025
- 160 Pages
Global
From €4195EUR$4,750USD£3,629GBP
- Report
- May 2025
- 120 Pages
Global
From €4195EUR$4,750USD£3,629GBP
- Report
- July 2024
- 100 Pages
Global
From €3312EUR$3,750USD£2,865GBP
- Report
- July 2024
- 150 Pages
Global
From €3312EUR$3,750USD£2,865GBP
- Report
- July 2024
- 100 Pages
Global
From €3312EUR$3,750USD£2,865GBP
- Report
- July 2024
- 100 Pages
Global
From €3312EUR$3,750USD£2,865GBP
- Report
- December 2024
- 200 Pages
Global
From €3312EUR$3,750USD£2,865GBP

The Polymerase Chain Reaction (PCR) market is a subset of the genomics industry. It is a technology used to amplify and replicate DNA sequences, allowing for the detection and analysis of genetic material. PCR is used in a variety of applications, including diagnostics, forensics, and research. It is a key tool in the development of personalized medicine, as it allows for the detection of genetic mutations and other biomarkers. PCR is also used in the development of gene therapies, as it allows for the insertion of new genetic material into cells.
The PCR market is highly competitive, with a number of companies offering products and services. These include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, QIAGEN, and Roche. Show Less Read more